Upsher-Smith Laboratories, LLC, a United States-based pharmaceutical company, announced on Monday that it has launched its Pitavastatin Tablets in 1mg, 2mg, and 4mg strengths.

The product is an AB-rated, generic equivalent to the brand product, LIVALO (pitavastatin) tablets.

Sawai USA, Inc, a company of Sawai Group Holdings Co., Ltd. (Sawai), has the ANDA for Pitavastatin tablets and it represents Sawai's first Paragraph IV product to be introduced in the United States. The company is distributing the product in the United States.